Polidexa with phenylephrine (neomycin sulfate) nasal spray 15 ml.

$23.50

Polidexa has an antibacterial, vasoconstrictor effect of phenylephrine, as well as a local anti-inflammatory effect. Due to these indicators, the drug is prescribed for the treatment of acute rhinitis and acute sinusitis. The positive effect of the treatment with this drug is due to the unique combination of these antibiotics, which expands the spectrum of antimicrobial action against bacteria that usually cause inflammation of the nasal cavity. At the same time, the vasoconstrictor effect of phenylephrine reduces nasal congestion.

Description

Polidexa Composition
The main components: neomycin sulfate and polymyxin B sulfate, as well as phenylephrine hydrochloride and dexamethasone sodium metasulfobenzoate, excipients

Release form
Nasal spray, solution (clear liquid), 15 ml

Indications
Polidexa has an antibacterial, vasoconstrictor effect of phenylephrine, as well as a local anti-inflammatory effect. Due to these indicators, the drug is prescribed for the treatment of acute rhinitis and acute sinusitis. The positive effect of the treatment with this drug is due to the unique combination of these antibiotics, which expands the spectrum of antimicrobial action against bacteria that usually cause inflammation of the nasal cavity. At the same time, the vasoconstrictor effect of phenylephrine reduces nasal congestion.

Contraindications
The drug should not be used if there is a suspicion that the patient is currently developing angle-closure glaucoma or has kidney disease. It is forbidden to use it simultaneously with treatment with MAO inhibitors (a special group of antidepressants). Contraindicated in viral infections, as well as in hypersensitivity to drug components.
It is forbidden to prescribe the drug if the patient suffers from severe coronary insufficiency, severe or severely treatable hypertension, as well as if he occasionally has convulsions.
Do not use the drug if the patient has nasal infections that are caused by the herpes virus or chickenpox.

Children
It is forbidden to appoint children under 15 years old

Application during pregnancy and lactation
Not applicable

Method of administration and dosage
Adults – 1 injection 3-5 times a day. Children over 15 years old – 1 injection 3 times a day. The course of treatment is up to 5 days. Do not swallow Polidexa with phenylephrine!
When injecting, the bottle should be held vertically, at the same time the head should be tilted forward. Otherwise, the medicine will enter the nasal passage in the form of a stream of water, and not a spray, which will not have the desired therapeutic effect.

Overdose
If the course of treatment is exceeded, or if the recommended dose is significantly exceeded, the drug can cause hypothermia, respiratory depression, sedation and, finally, coma.

Side effects
There may be negative side effects such as tachycardia, myocardial infarction. The gastrointestinal tract can respond to ingestion by nausea, vomiting, and dry mouth. Sleep disturbances are possible in the form of insomnia caused by excitement of the nervous system, ischemic stroke and convulsions may develop. With diseases of the genitourinary system, difficulty in urinating may occur. Itching, hives, and rashes may occur on the skin.

Storage conditions and periods
Polidexa can be stored for 3 years in a dry place at an ambient temperature not exceeding + 25 ° С